Quick Takeaways
- Jonathan D. Root has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $28,234,350.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jonathan D. Root
- Location
- Menlo Park, CA
- Summary
- The estimated net worth of Jonathan D. Root is at least $28,234,350 dollars as of 07 Apr 2026. Jonathan D. Root is the Director of CARLSMED, INC. and owns shares of CARLSMED, INC. (CARL) stock worth about $23.23M. Jonathan D. Root is the Director, 10%+ Owner of eFFECTOR Therapeutics, Inc. and owns shares of eFFECTOR Therapeutics, Inc. (EFTR) stock worth about $2.74M. Jonathan D. Root is the Director of Omada Health, Inc. and owns shares of Omada Health, Inc. (OMDA) stock worth about $2.26M.
- Signature
- /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jonathan D. Root and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: CARLSMED, INC. ($23,225,260).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jonathan D. Root
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CARL | CARLSMED, INC. | Director | $23,225,260 | 22 Jul 2025 | ||
| EFTR | eFFECTOR Therapeutics, Inc. | Director, 10%+ Owner | $2,744,147 | 02 Dec 2021 | ||
| OMDA | Omada Health, Inc. | Director | $2,264,943 | 05 Apr 2026 | ||
| NARI | Inari Medical, Inc. | Director | $0 | 19 Feb 2025 | ||
| EWTX | Edgewise Therapeutics, Inc. | Director | 16 Jun 2025 | |||
| SPRY | Silverback Therapeutics, Inc. | Director | 10 Jun 2022 |
Insider Transactions Reported by Jonathan D. Root:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.